IndigoBay Ventures is a leading provider of strategic scientific and FDA regulatory consulting services.
We know innovation requires good science, and good science is good medicine. For every client engagement, we rely on the best experts. Our clinical and regulatory solutions are data-driven and reflect decades of successful industry experience.
We value and build long-term relationships based on integrity, outcomes, and service.
We specialize in value-added scientific and regulatory services essential to developing innovative healthcare products and improving patient care.
Each client engagement is executed with a commitment to scientific excellence, and reliance on well qualified experts.
Original cost to sequence the human genome, completed in 2003, after 13 years of effort. Today, it can be done in 2 weeks for $7,700.
Source: WH National Bioeconomy Blueprint, 2012
